OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intracellular mono-ADP-ribosyltransferases at the host–virus interphase
Bernhard Lüscher, Maud Verheirstraeten, Sarah Krieg, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 16

Showing 16 citing articles:

Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9

Anti-viral defense by an ADP-ribosyltransferase that targets mRNA to block translation
Christopher N. Vassallo, Christopher R. Doering, Michael T. Laub
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7

Recurrent Loss of Macrodomain Activity in Host Immunity and Viral Proteins
Sofia E. Delgado-Rodriguez, Andrew P. Ryan, Matthew D. Daugherty
Pathogens (2023) Vol. 12, Iss. 5, pp. 674-674
Open Access | Times Cited: 15

Zinc-finger PARP proteins ADP-ribosylate alphaviral proteins and are required for interferon-γ–mediated antiviral immunity
Andrew P. Ryan, Sofia E. Delgado-Rodriguez, Matthew D. Daugherty
Science Advances (2025) Vol. 11, Iss. 5
Open Access

Mono-ADP-ribosylation by PARP10 inhibits Chikungunya virus nsP2 proteolytic activity and viral replication
Sarah Krieg, Fabian Pott, Laura Potthoff, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 3
Open Access | Times Cited: 12

Emerging Role of Nicotinamide Riboside in Health and Diseases
Chiranjeev Sharma, Dickson Donu, Yana Cen
Nutrients (2022) Vol. 14, Iss. 19, pp. 3889-3889
Open Access | Times Cited: 16

PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology
Barbara Morone, Giovanna Grimaldi
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 2

Anti-viral defence by an mRNA ADP-ribosyltransferase that blocks translation
Christopher N. Vassallo, Christopher R. Doering, Michael T. Laub
Nature (2024)
Open Access | Times Cited: 2

ADP-Ribosylation in Antiviral Innate Immune Response
Qian Du, Ying Miao, Wei He, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 303-303
Open Access | Times Cited: 6

Monitoring nucleolar-nucleoplasmic protein shuttling in living cells by high-content microscopy and automated image analysis
Marina Engbrecht, David Grundei, Asisa M Dilger, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 15, pp. e72-e72
Open Access | Times Cited: 1

Pathological and physiological roles of ADP-ribosylation: established functions and new insights
Karla L. H. Feijs, Nonso Josephat Ikenga, Roko Žaja
Biological Chemistry (2024) Vol. 405, Iss. 9-10, pp. 567-581
Closed Access | Times Cited: 1

IFN-Induced PARPs—Sensors of Foreign Nucleic Acids?
Katharina Biaesch, Sarah Knapp, Patricia Korn
Pathogens (2023) Vol. 12, Iss. 3, pp. 457-457
Open Access | Times Cited: 4

Discovery of 2-amide-3-methylester thiophenes that target SARS-CoV-2 Mac1 and repress coronavirus replication, validating Mac1 as an anti-viral target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

Pathogenesis and clinical features of severe hepatitis E virus infection
László Orosz, Károly Péter Sárvári, Áron Dernovics, et al.
World Journal of Virology (2024) Vol. 13, Iss. 2
Open Access

PARP14 mediated SQSTM1/p62 cysteine ADP-ribosylation is counteracted by the SARS-CoV-2 macrodomain
David Kubon, Deena M. Leslie Pedrioli, Michael O. Hottiger
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Page 1

Scroll to top